Captrust Financial Advisors Has $3.78 Million Position in DocuSign, Inc. (NASDAQ:DOCU)

Captrust Financial Advisors raised its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 8.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,989 shares of the company's stock after purchasing an additional 3,402 shares during the period. Captrust Financial Advisors' holdings in DocuSign were worth $3,776,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Kestra Investment Management LLC acquired a new position in shares of DocuSign during the fourth quarter worth approximately $30,000. First Horizon Advisors Inc. grew its position in DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock worth $36,000 after purchasing an additional 201 shares during the last quarter. Bessemer Group Inc. grew its position in DocuSign by 490.0% in the 4th quarter. Bessemer Group Inc. now owns 472 shares of the company's stock worth $42,000 after purchasing an additional 392 shares during the last quarter. Avion Wealth increased its holdings in shares of DocuSign by 309.2% during the 4th quarter. Avion Wealth now owns 487 shares of the company's stock worth $43,000 after purchasing an additional 368 shares during the period. Finally, Avior Wealth Management LLC raised its position in shares of DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company's stock valued at $49,000 after buying an additional 145 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Insider Buying and Selling

In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the completion of the sale, the chief financial officer now owns 77,851 shares of the company's stock, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the transaction, the director now directly owns 8,270 shares in the company, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 55,851 shares of company stock worth $4,607,439 over the last three months. 1.01% of the stock is currently owned by company insiders.

DocuSign Stock Down 1.0 %

Shares of NASDAQ DOCU opened at $83.29 on Friday. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The firm's 50-day simple moving average is $80.15 and its 200 day simple moving average is $84.48. The company has a market cap of $16.87 billion, a price-to-earnings ratio of 17.17, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same period in the prior year, the business earned $0.76 earnings per share. DocuSign's quarterly revenue was up 9.0% on a year-over-year basis. On average, equities analysts expect that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on DOCU. Wedbush restated a "neutral" rating and set a $100.00 price target on shares of DocuSign in a research note on Friday, March 14th. Morgan Stanley reduced their target price on DocuSign from $97.00 to $92.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 16th. William Blair reissued an "outperform" rating on shares of DocuSign in a report on Monday, April 21st. JPMorgan Chase & Co. raised shares of DocuSign from an "underweight" rating to a "neutral" rating and raised their price objective for the stock from $70.00 to $75.00 in a report on Monday, March 10th. Finally, Citigroup upped their target price on shares of DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $92.46.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.